Are you unsure about some of the terminology used by specialists who are preparing your evidence dossier? Here our experts answer some of the most frequently asked questions about systematic literature reviews and network meta-analysis.
‘Time to event’ or ‘survival’ is an important endpoint used in efficacy assessments of medical interventions, particularly in disease areas such as oncology. The Cox proportional hazards (PH) model is…
Continuous outcomes data from trials may be categorised using pre-defined cut-offs to generate ordered categorical outcomes data. Usually the percentage of patients who have improved by certain thresholds are reported…
Network meta-analysis (NMA) is a key tool for researchers and decision makers that allows the efficacy and safety of any number of healthcare interventions to be compared simultaneously. However, a…